Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Period	PE Ratio
2016-12-31	42.27
2017-12-31	34.39
2018-12-31	35.92
2019-12-31	30.44
2020-12-31	18.23
2021-12-31	12.21
2022-12-31	23.90
2023-12-31	25.51
2024-12-31	24.88
2025-12-31	21.83

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DGX	$193.60	-0.82%	0.28M
3
4
5

Quest Diagnostics Incorporated (DGX) PE Ratio

PE Ratio Data

Get Quest Diagnostics Incorporated Data in Excel

More DGX Financial Data